New measles surveillance data from WHO
Measles outbreaks continue to spread rapidly around the world, according to the latest preliminary reports provided to the World Health Organization (WHO), with millions of people globally at risk of the disease.
In the first six months of 2019, reported measles cases are the highest they have been in any year since 2006, with outbreaks straining health care systems, and leading to serious illness,... read more
FDA warns consumers about dangerous and potentially life-threating side effects of Miracle Mineral Solution
The U.S. Food and Drug Administration is warning consumers not to purchase or drink a product sold online as a medical treatment due to a recent rise in reported health issues. Since 2010, the FDA has warned consumers about the dangers of Miracle or Master Mineral Solution, Miracle Mineral Supplement, MMS, Chlorine Dioxide (CD) Protocol, Water Purification Solution (WPS) and other similar products... read more
Scientists hail promise of first effective Ebola treatments in Congo trial
Scientists are a step closer to finding the first effective treatments for the deadly Ebola hemorrhagic fever after two potential drugs showed survival rate of as much as 90% in a clinical trial in Congo.
Two experimental drugs - Regeneron's REGN-EB3 and a monoclonal antibody called mAb114 - were both developed using antibodies harvested from survivors of Ebola infection.... read more
Little Progress Seen in Diabetes Care in Past 15 Years
There have been few improvements in diabetes diagnosis, linkage of patients to care, or achievement of treatment targets in the United States since 2005 despite advances in care, new research suggests.
The findings, from 2488 participants in the National Health and Nutrition Examination Survey (NHANES) cycles covering 2005 to 2016, were published online August 12 in JAMA Internal Medicine.... read more
New Data on Antidepressants and Stroke Risk
Use of antidepressants that strongly inhibit serotonin is associated with a somewhat lower risk for ischemic stroke compared to agents that weakly inhibit the neurotransmitter, suggests a large, population-based study.
Investigators found a 12% reduced risk for ischemic stroke among study participants who were currently taking a stronger selective serotonin-reuptake inhibitor (SSRI)... read more